Clinical Studies
FFM, in supporting HCFMUSP and FMUSP, has actively participated in Clinical Studies, the results of which are of great interest to the academic community and society in general. The carrying out of Clinical Studies, under the supervision of the House's professors, is intended to evaluate the efficacy, tolerability and safety of medicines and research in human beings and animals, under the technical-scientific, ethical, framework in current legislation aspects for the species, research funding, source of resources, return on investment, adaptation to the Institutional policy guidelines, integration with other sectorial actions, and interest and convenience for the Public Service.
This work is carried out in partnership with the HC-FMUSP CLINICAL RESEARCH OFFICE
(EPeClin), linked to the Clinical Board of HCFMUSP and aims to support researchers, adapt
procedures and advise the areas of the FM-USP Complex and HC-FMUSP that carry out
scientific investigation processes involving human beings.
A Clinical Study is understood to be any investigation on human beings, aiming to discover or
verify the pharmacodynamic, pharmacological, clinical and/or other effects of product(s)
and/or to identify adverse reactions to the product(s) under investigation with the objective of
verify its safety and/or effectiveness. Clinical Research, clinical trial or clinical study are the
terms used to describe a scientific investigation process involving human beings. In this
context, the FFM currently manages around 349 clinical studies, approved by the Ethics
Committee for the Analysis of Research Projects at HCFMUSP (CAPPesq) and coordinated by
researchers from the Complex.
Below are the files with information and forms necessary to carry out Clinical Studies